Adipokines and Their Role in Intestinal Inflammation

Fat tissue was initially described for its endocrine and metabolic function. Over the last two decades increasing evidence indicated a close interaction with the immune system. Partly responsible for this immune modulatory function are soluble factors released by the fat tissue, most prominently the...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 9; p. 1974
Main Authors Weidinger, Carl, Ziegler, Jörn F, Letizia, Marilena, Schmidt, Franziska, Siegmund, Britta
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 12.10.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fat tissue was initially described for its endocrine and metabolic function. Over the last two decades increasing evidence indicated a close interaction with the immune system. Partly responsible for this immune modulatory function are soluble factors released by the fat tissue, most prominently the so-called adipokines. These discoveries led to the question how adipokines influence inflammatory diseases. Linking inflammation and adipose tissue, Crohn's disease, a chronic inflammatory bowel disease, is of particular interest for studying the immune modulatory properties of adipokines since it is characterized by a hyperplasia of the mesenteric fat that subsequently is creeping around the inflamed segments of the small intestine. Thus, the role of several adipokines in the creeping fat as well as in intestinal inflammation was recently explored. The present review selected the four adipokines adiponectin, apelin, chemerin, and leptin and provides a working model based on the available literature how these factors participate in the maintenance of intestinal immune homeostasis.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
This article was submitted to Cytokines and Soluble Mediators in Immunity, a section of the journal Frontiers in Immunology
Reviewed by: Angela Bonura, Consiglio Nazionale Delle Ricerche (CNR), Italy; Giovanna Montana, Istituto di biomedicina e di immunologia molecolare Alberto Monroy (IBIM), Italy
Edited by: Fabio Cominelli, Case Western Reserve University, United States
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.01974